Cas:34836-53-8 Copper(I) iodide trimethylphosphite manufacturer & supplier

We serve Chemical Name:Copper(I) iodide trimethylphosphite CAS:34836-53-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Copper(I) iodide trimethylphosphite

Chemical Name:Copper(I) iodide trimethylphosphite
CAS.NO:34836-53-8
Synonyms:EINECS 252-237-6;(trimethyl phosphite) copper(I) iodide;MFCD00034815;iodo(trimethyl phosphite-P)copper;CUPROUS IODIDE TRIMETHYLPHOSPHITE COMPLEX;trimethyl phosphite-copper(I) iodine;Copper(I) iodide trimethyl phosphite complex,Cuprous iodide trimethylphosphite complex;CuI* P(OMe)3;IODO(TRIMETHYL PHOSPHITE)COPPER(I);COPPER(I) IODIDE-TRIMETHYL PHOSPHITE COMPLEX
Molecular Formula:C3H9CuIO3P
Molecular Weight:314.52600
HS Code:

Physical and Chemical Properties:
Melting point:192-193ºC (dec.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:41.28000
Exact Mass:313.86300
LogP:2.03570

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like EINECS 252-237-6 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,COPPER(I) IODIDE-TRIMETHYL PHOSPHITE COMPLEX physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Copper(I) iodide trimethyl phosphite complex,Cuprous iodide trimethylphosphite complex Use and application,EINECS 252-237-6 technical grade,usp/ep/jp grade.


Related News: For these reasons, many pharmaceutical companies are choosing to evaluate biocatalytic processes during early-stage drug development to avoid missing opportunities for capitalizing on these gains. 4-Nitrosalicylic Acid manufacturers The review considered two cases of AML in patients treated with an investigational medicine, bb1111, in a clinical trial for sickle cell disease. Although there have been no reports of AML with Zynteglo, both medicines use the same viral vector and there was a concern that the vector may be implicated in the development of the cancer (insertional oncogenesis). cefaloglycin suppliers Mindset Pharma Inc. is a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. 5-Bromo-2-ethoxypyrimidine vendor & factory.